Original article| Volume 23, SUPPLEMENT 1, S127-S132, December 2001

Download started.


Substance P immunoreactivity in the enteric nervous system in Rett syndrome


      Rett syndrome is associated with profound mental retardation and motor disability in girls. It has a characteristic clinical phenotype which includes abnormalities of the autonomic nervous system. Feeding impairment and severe constipation are two symptoms of this autonomic dysfunction. Substance P, an important peptide in the autonomic nervous system, is decreased in the cerebrospinal fluid of Rett syndrome. We have demonstrated that substance P immunoreactivity is significantly decreased in Rett syndrome brain-stem and may be related to the autonomic dysfunction. In this study, we have continued the investigation of substance P in the enteric nervous system. We immunohistochemically examined the normal developing bowel in 22 controls (ages, 14 gestational weeks to 31 years) using formalin fixed tissue, with antibodies to substance P, tyrosine hydroxylase and vasoactive intestinal peptide. We compared the immunoreactivity of normal controls with 14 cases of Rett syndrome (ages, 5–41 years) and observed that the expression of substance P, tyrosine hydroxylase and vasoactive intestinal peptide immunoreactivity in the bowel in Rett syndrome was not significantly different from that of controls. This suggests that the feeding impairment and constipation in Rett syndrome relate to dysfunction of the autonomic nervous system originating outside of the bowel, in the brain-stem, as suggested by our previous study.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rett A.
        Cerebral atrophy associated with hyperammonemia.
        in: Vinken P.W. Bruyn G.W. Handbook of clinical neurology. 1977: 305-325
        • Motil K.J.
        • Schultz R.J.
        • Browning K.
        • Trautwein A.L.
        • Glaze D.G.
        Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome.
        J Pediatr Gastroenterol Nutr. 1999; 29: 31-37
        • Morton E.
        • Bonas R.
        • Minford J.
        • Kerr A.
        • Ellis R.E.
        Feeding ability in Rett syndrome.
        Dev Med Child Neurol. 1997; 39: 331-335
        • Witt Engerstrom I.
        • Kerr A.
        Workshop on autonomic function in Rett syndrome. Swedish Rett Center, Frosen, Sweden, May 1998.
        Brain Dev. 1998; 20: 323-326
        • Mitzuishi Shoji H.
        • Kato H.
        • Percy A.K.
        Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome.
        Ann Neurol. 1997; 42: 978-981
        • Deguchi K.
        • Antalffy B.
        • Twohill L.J.
        • Chakrabory S.
        • Glaze D.G.
        • Armstrong D.D.
        Substance P immunoreactivity in Rett syndrome.
        Pediatr Neurol. 2000; 22: 259-266
        • Goyal R.K.
        • Hirano I.
        The enteric nervous system.
        N Engl J Med. 1996; 334: 1106-1115
        • Madera J.L.
        • Trier J.S.
        The functional morphology of the mucosa of the small intestine.
        in: Johnson L.R. Physiology of the gastrointestinal tract. 3rd ed. 1994: 1577-1622
        • Malandrini A.
        • Hayek G.
        • Villanova M.
        • Aucone A.M.
        • Berti G.
        • Vernillo R.
        • et al.
        Ultrastructural study of enteric ganglia in three patients with Rett syndrome.
        Brain Dev. 1998; 20: 586-588
        • Nan X.
        • Campoy J.
        • Bird A.
        MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
        Cell. 1997; 88: 471-481
        • Guy J.
        • Hendrich B.
        • Holmes M.
        • Martin J.E.
        • Bird A.
        A mouse Mecp2-null mutation causes neurologic symptoms that mimic Rett syndrome.
        Nat Genet. 2001; 27: 322-326
        • Chen R.Z.
        • Akbarian S.
        • Tudor M.
        • Jaenisch R.
        Deficiency of methyl–CpG binding protein-2 in CNS neurons results in a Rett phenotype in mice.
        Nat Genet. 2001; 27: 327-331
        • Roth K.A.
        • Herz J.M.
        • Gordon J.I.
        Mapping enteroendocrine cell populations in transgenic mice reveals an unexpected degree of complexity in cellular differentiation within the gastrointestinal tract.
        J Cell Biol. 1990; : 1791-1801